Prof. Hod is a global opinion leader in the field of women’s health and the President of the European Association of Perinatal Medicine (EAPM). A Professor of Obstetrics and Gynecology at the Sackler Faculty of Medicine, Tel-Aviv University, Prof. Hod serves as a Chief Consultant for Perinatal Medicine to Clalit Health Services, Israel’s largest health organization, and the Director of Mor Women’s Health Center.
Prof. Hanuš is a world-renowned analytical chemist and a leading figure in the field of cannabis research, responsible for groundbreaking research in the vast realm of cannabinoids. His award-winning research serves as the basis for much of what we know about the plant today. In 1992, Prof. Hanuš isolated the first known endocannabinoid in the human brain, Anandamide, named after the Sanskrit word for bliss. The discovery confirmed that the human brain produces ״cannabinoids״ of its own, called endocannabinoids, which bind with cannabinoid receptors throughout the brain and body, paving the way for decades of research into medical cannabis use.
Dr. Prutchi Sagiv has over 15 years of experience in various aspects of pharmaceutical development including discovery, regulatory affairs, intellectual property, business development, clinical trials, and marketing. Dr. Sagiv has led the Scientific Operations in multiple cannabis-based drug companies including Talent Biotech and BOL Pharma. She serves as Director of Tech Transfer at Mor Research Applications (Clalit Health Services commercializing arm), where she is responsible for raising capital via strategic partnerships for early stage technologies.
Director Of Global Relations
Meredith Rose Burak, former executive at Merrill Lynch, facilitates innovative solutions across the fields of advocacy, philanthropy and for-profit investing to create worldwide economic and political change. Meredith provided strategic investment and philanthropic advice to her clients, managing hundreds of millions of dollars in assets. In honor of her mother, Meredith founded and presides over the Mary Haas Ovarian Cancer Early Detection Foundation to fund awareness and research initiatives to combat the disease. Passionate about education and empowering future leaders, Burak is the youngest professional on the board of directors of Hillel International.
Esther Barak Landes is one of the most prolific and successful tech deal-makers in Israel, with over 20 years of experience building and investing in technology companies jointly worth several billions of dollars. Barak’s business expertise covers a broad range of activities including legal counseling, business development, fundraising, M&A, IPO’s, and hands-on management. Barak is also involved in several non-profit organizations and serves as the President of ProWoman, an organization promoting female leadership in Israel.
Dr. Kaufman is a Senior Consultant at the Department of Obstetrics & Gynecology at Carmel Medical Center and Assuta Private Hospital. He also founded and heads the Multidisciplinary Center for the Treatment of Endometriosis, the leading center for patients with endometriosis in the north of Israel. Dr. Kaufman is a Clinical Lecturer at Technion (Israel Institute of Technology), a member of the European and American Endoscopy societies (ESGE and AAGL) and the World Endometriosis Society (WES).
Lenore co-founded the Group for ADHD, LLC, a multi-disciplined clinic providing full diagnostics and treatment for adults, children, and families living with ADHD and/or learning disabilities dedicated to providing a combination of both traditional and alternative treatments. Ruben serves as the President of ELEM America, a nonprofit organization committed to treating and transforming the lives of troubled youth, is a member of the Hillel International Board of Governors, and sits on the board of the Bronfman Center at NYU.